Hackensack Meridian Children’s Health Pediatric Oncology Experts
Offering cutting-edge treatment protocols and hands-on care from newborns to young adults
Hackensack Meridian Children’s Health pediatric oncologists are leading cutting-edge clinical research while providing diagnosis and treatment of leukemia, lymphoma, neuroblastoma, bone, brain and kidney tumors, as well as rare tumor types.
If you are a patient looking for expert pediatric cancer care at Hackensack Meridian Health, please visit our pediatric cancer care services page to learn about our specialties, find locations, and schedule appointments.
HMCH Brings Clinical Trials for Rare Pediatric Brain Tumors to Tristate Area
Hackensack Meridian Children’s Health is the only pediatric health network in the tristate area participating in two clinical trials through the Pediatric Neuro-Oncology Consortium (PNOC) to explore new therapies for children diagnosed with rare, aggressive brain tumors that lack a standard of care or have few available treatment options.
Research Identifies Potential Treatment Targets for Rare Childhood Brain Tumors
Pediatric neuro-oncologists at Hackensack Meridian Children’s Health published research on embryonal tumor with multilayered rosettes (ETMR) and atypical teratoid/rhabdoid tumor (ATRT), identifying potential new treatment targets for these aggressive pediatric brain cancers with poor prognoses and no standard treatments.
First Patient Completes Treatment with Curative Gene Therapy for Sickle Cell Disease
An 18-year-old patient has been discharged after receiving curative treatment for sickle cell disease with the FDA-approved gene-modifying therapy Lyfgenia™ at Hackensack Meridian Children’s Health Joseph M. Sanzari Children’s Hospital.
Researchers Identify New Target for AML Immunotherapy
Hackensack Meridian Children’s Health researchers have identified a promising novel immunotherapy target for acute myeloid leukemia (AML).
Young Investigator Grant Supports Promising Pediatric AML Research
Hackensack Meridian Children’s Health pediatric hematologist-oncologist Ashley Varkey, D.O., received a $300,000 Young Investigator Grant through the Hyundai Hope on Wheels program to fund pediatric acute myeloid leukemia (AML) research.